WHO Honors Irish Doctor for Global Health Emergency Work
An Irish physician received a 2026 Director-General's Award for contributions to international health emergency systems. His efforts include establishing a global disease response network and leading responses to multiple outbreaks.
kff.orgThe award recognizes his role in founding the Global Outbreak Alert and Response Network, which has supported responses to hundreds of disease outbreaks worldwide.
He led the organization's response to major health emergencies including SARS, Ebola, and COVID-19. The physician also served as Executive Director of the Health Emergencies Programme, shaping how the world detects, prepares for, and responds to health threats. His work has focused on protecting vulnerable communities and improving global health security.
The Global Outbreak Alert and Response Network has coordinated international efforts during outbreaks across multiple continents. Officials noted that the network's activities have helped standardize detection and response procedures used by health authorities in many countries.
The award ceremony highlighted the physician's decades of service in building coordinated systems for managing health crises.
“Dr Mike Ryan from Ireland is honored with 2026 Director-General's Awards for Global Health at WHA79 for his leadership in strengthening global health emergency preparedness and response." — Award citation, 2026 His contributions have supported responses to outbreaks that affected populations in both high-income and low-income settings.”
Key Facts
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.